Filter Results:
(3,068)
Show Results For
- All HBS Web
(3,068)
- People (6)
- News (678)
- Research (1,769)
- Events (14)
- Multimedia (14)
- Faculty Publications (895)
Show Results For
- All HBS Web
(3,068)
- People (6)
- News (678)
- Research (1,769)
- Events (14)
- Multimedia (14)
- Faculty Publications (895)
- September 2004 (Revised July 2006)
- Supplement
Battle of the Bulge: Private and Public Solutions for Obesity (B)
By: Regina E. Herzlinger and Louisa Neissa
Supplements the (A) case. View Details
Herzlinger, Regina E., and Louisa Neissa. "Battle of the Bulge: Private and Public Solutions for Obesity (B)." Harvard Business School Supplement 305-027, September 2004. (Revised July 2006.)
- 2010
- Working Paper
Evaluating the Effects of Large-Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative
By: Nava Ashraf, Gunther Fink and David N. Weil
Since 2003, Zambia has been engaged in a large-scale, centrally coordinated national anti-malaria campaign which has become a model in sub-Saharan Africa. This paper aims at quantifying the individual and macro level benefits of this campaign, which involved mass... View Details
Keywords: Cost vs Benefits; Developing Countries and Economies; Health Care and Treatment; Health Disorders; Performance Evaluation; Programs; Health Industry; Zambia
Ashraf, Nava, Gunther Fink, and David N. Weil. "Evaluating the Effects of Large-Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative." NBER Working Paper Series, No. 16069, June 2010.
- September–October 2022
- Article
Case Study: What's the Right Career Move After a Public Failure?
By: Jon M. Jachimowicz and Francesca Gino
“Reunions are for happy people,” Mariani Kallis said to her friend Whitney on the phone. “I’m not going.” “Come on, it won’t be the same without you,” Whitney pleaded. “Besides, no one is happy right now. Everyone’s life is a mess.”
“I’m pretty sure none of our... View Details
Jachimowicz, Jon M., and Francesca Gino. "Case Study: What's the Right Career Move After a Public Failure?" Harvard Business Review 100, no. 5 (September–October 2022): 144–149.
- Web
Value-Based Health Care - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care Health Care Courses Fast Facts Value-Based Health Care... View Details
- 2016
- Blog
Building A Culture of Health - John A. Quelch: The Marketing of Prevention
By: John A. Quelch
The US will devote 17.5% of GDP to health care this year, around $3 trillion. Yet only 3 percent of that will be spent on prevention, including both primary prevention (preventing illness in the first place) and secondary prevention (preventing sick people getting... View Details
Keywords: Healthcare; Healthcare Marketing; Prevention; Wellbeing; Health; Marketing; Health Industry; Health Industry; Health Industry; Europe; North and Central America
Quelch, John A. "The Marketing of Prevention." Building A Culture of Health - John A. Quelch (blog). May 12, 2016. http://johnquelch.org/the-marketing-of-prevention/.
- Article
Moral Dilemmas and Trust in Leaders during a Global Health Crisis
By: Jim A. C. Everett, Clara Colombatto, Edmond Awad, Paulo Boggio, Björn Bos, William J. Brady, Megha Chawla, Vladimir Chituc, Dongil Chung, Moritz A. Drupp, Shristi Goel, Brit Grosskopf, Frederik Hjorth, Alissa Ji, Caleb Kealoha, Judy S. Kim, Yangfei Lin, Yina Ma, Michel André Maréchal, Federico Mancinelli, Christoph Mathys, Asmus L. Olsen, Graeme Pearce, Annayah M. B. Prosser, Niv Reggev, Nicholas Sabin, Julien Senn, Yeon Soon Shin, Walter Sinnott-Armstrong, Hallgeir Sjåstad, Madelijn Strick, Sunhae Sul, Lars Tummers, Monique Turner, Hongbo Yu, Yoonseo Zoh and Molly J. Crockett
Trust in leaders is central to citizen compliance with public policies. One potential determinant of trust is how leaders resolve conflicts between utilitarian and non-utilitarian ethical principles in moral dilemmas. Past research suggests that utilitarian responses... View Details
Keywords: COVID-19 Pandemic; Impartial Beneficence; Utilitarian Responses; Trust; Ethics; Public Opinion; Leadership Style
Everett, Jim A. C., Clara Colombatto, Edmond Awad, Paulo Boggio, Björn Bos, William J. Brady, Megha Chawla, Vladimir Chituc, Dongil Chung, Moritz A. Drupp, Shristi Goel, Brit Grosskopf, Frederik Hjorth, Alissa Ji, Caleb Kealoha, Judy S. Kim, Yangfei Lin, Yina Ma, Michel André Maréchal, Federico Mancinelli, Christoph Mathys, Asmus L. Olsen, Graeme Pearce, Annayah M. B. Prosser, Niv Reggev, Nicholas Sabin, Julien Senn, Yeon Soon Shin, Walter Sinnott-Armstrong, Hallgeir Sjåstad, Madelijn Strick, Sunhae Sul, Lars Tummers, Monique Turner, Hongbo Yu, Yoonseo Zoh, and Molly J. Crockett. "Moral Dilemmas and Trust in Leaders during a Global Health Crisis." Nature Human Behaviour 5, no. 8 (August 2021): 1074–1088.
- 08 Mar 2017
- Op-Ed
Op-Ed: Can the Proposed American Health Care Act Improve on 'Obamacare'?
it passes in Congress. About the Authors John A. Quelch is the Charles Edward Wilson Professor of Business Administration at Harvard Business School. He also holds a joint appointment at Harvard T.H. Chan School of Public View Details
- 12 Jul 2004
- Research & Ideas
Michael Porter’s Prescription For the High Cost of Health Care
We believe that competition is the root of the problem with U.S. health care performance. But this does not mean we advocate a state-controlled system or a single-payer system; those approaches would only make matters worse. On the... View Details
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details
Keywords: Health Disorders; Health Care and Treatment; Private Sector; Public Sector; Alliances; Problems and Challenges; Africa; Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (B): Botswana." Harvard Business School Case 301-089, January 2001.
- Article
Design and Testing of a Mobile Health Application Rating Tool
By: David Levine, Zo Co, Lisa Newmark, Alissa Groisser, A Jay Holmgren, Jennifer Haas and David Bates
Mobile health applications (“apps”) have rapidly proliferated, yet their ability to improve outcomes for patients remains unclear. A validated tool that addresses apps’ potentially important dimensions has not been available to patients and clinicians. The objective of... View Details
Levine, David, Zo Co, Lisa Newmark, Alissa Groisser, A Jay Holmgren, Jennifer Haas, and David Bates. "Design and Testing of a Mobile Health Application Rating Tool." Art. 74. npj Digital Medicine 3 (2020).
- 2016
- Chapter
Evaluating the Effects of Large Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative
By: Nava Ashraf, Gunther Fink and David N. Weil
Since 2003, Zambia has been engaged in a large-scale, centrally coordinated national anti-Malaria campaign, which has become a model in sub-Saharan Africa. This paper aims at quantifying the individual and macro-level benefits of this campaign, which involved mass... View Details
Ashraf, Nava, Gunther Fink, and David N. Weil. "Evaluating the Effects of Large Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative." Chap. 1 in African Successes, Volume 2: Human Capital, edited by Sebastian Edwards, Simon Johnson, and David N. Weil. University of Chicago Press, 2016.
- 18 Oct 2016
- Op-Ed
Why Business Should Invest in Community Health
health than for the other three components of their health footprint. One reason may be the greater difficulty of measuring return on investment for community View Details
- March 2014 (Revised December 2014)
- Case
Vision 2020: Takeda and the Vaccine Business
By: John A. Quelch and Margaret L. Rodriguez
In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003... View Details
Keywords: Health Care; Global; NGO; Public Health; Japan; GSK; Vaccine; Supply Chain; Market Entry; Health; Health Care and Treatment; Trade; Market Entry and Exit; Global Strategy; Health Industry; Health Industry
Quelch, John A., and Margaret L. Rodriguez. "Vision 2020: Takeda and the Vaccine Business." Harvard Business School Case 514-084, March 2014. (Revised December 2014.)
- 21 Nov 2012
- Research & Ideas
What Health Care Managers Need to Know--and How to Teach Them
Confronting Challenges for Innovation with a Modern Curriculum." The conference brought together 114 global faculty from schools of medicine, health care administration, public health, and business; leaders... View Details
- Web
Increasing Value in Care Delivery - Health Care
Impact Increasing Value in Care Delivery Why an MD/MBA from HBS and HMS? Tobi Ogbechie Health Minute: Measure Costs Correctly for Better Patient Outcomes Health Minute: The... View Details
- 20 Jul 2020
- Op-Ed
It's Time for a Bipartisan Health Plan for Employers and Employees
arrangements (HRA) rule and Joe Biden’s Public Option would go a long way to bringing more choice, affordability, and personal control to the purchase of health insurance. Trump’s rule enables employees in... View Details
- 02 Mar 2007
- What Do You Think?
What Is the Government’s Role in US Health Care?
from government. Suggestions of causes of the current challenge of rapidly rising costs in relation to quality of outcomes, at least by the imperfect measure of life expectancy, included waste in the system (Julie Maire, Edward Hare, and... View Details
- August 2003 (Revised September 2008)
- Background Note
Note on Financing of the U.S. Health Care Sector
By: Regina E. Herzlinger and Jeff Grahling
This course describes the public and private sources of financing of the U.S. health-care sector,and identifies the characteristics of insurance policies, their costs, the structure of the insurance industry, and the role of consultants and brokers. The insurance... View Details
Keywords: Economic Sectors; Financing and Loans; Insurance; Industry Structures; Health Industry; Health Industry; United States
Herzlinger, Regina E., and Jeff Grahling. "Note on Financing of the U.S. Health Care Sector." Harvard Business School Background Note 304-039, August 2003. (Revised September 2008.)
- 07 Aug 2009
- What Do You Think?
Why Can’t Americans Get Health Care Right?
Original Article It is said that health care is the biggest threat to the long-term health of the U.S. economy and therefore, to some extent, the global economy. Americans pay much more for what they get (at... View Details